Dynamics of Immune Response in Irradiated Rectal Cancer
受照射直肠癌免疫反应的动态
基本信息
- 批准号:10517804
- 负责人:
- 金额:$ 171.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-21 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateAffectAgeArtificial IntelligenceBiologicalBiologyBiopsyBloodBlood specimenCellsClinicClinicalClinical InvestigatorClinical TrialsCollaborationsColonoscopyColorectalCommunitiesComplexComputersConsentDataDescriptorDisciplineEnvironmentEuropeFecesFertilizationFoundationsFutureGenderGenerationsGrantHarvestHumanImageImaging TechniquesImmuneImmune responseImmune systemImmunityImmunologistImmunologyImmunophenotypingInstitutionInternationalInvestigationIonizing radiationIrradiated tumorKnowledgeMachine LearningMagnetic Resonance ImagingMalignant NeoplasmsModelingMolecularNeoadjuvant TherapyNewly DiagnosedNormal tissue morphologyOperative Surgical ProceduresOutcomeOxidative StressPatientsPeripheral Blood Mononuclear CellPhysicsPreparationProceduresProcessPublicationsRadiationRadiation OncologyRadiation therapyRadiobiologyRadiometryRectal CancerRegulationResearchResearch PersonnelResource SharingSamplingScientistSpecimenStandardizationStructureSurvivorsSystemTechnologyTestingTissue BanksTissuesTrainingTranslationsTumor TissueTumor stagebiobankbioinformatics toolbiological effect of radiationdata acquisitiondata harmonizationdata sharingdesigneffective therapyexperienceinsightinternational centerlongitudinal analysislymph nodesmeetingsmicrobiomemultiple omicsnext generationnovelprospectiveradiation effectradiomicsresponsesimulationstandard carestool samplestudy characteristicstumor
项目摘要
ABSTRACT
Despite the recognition of the contribution of the immune system to cancer response to ionizing radiation,
successful translation to the clinic is lagging. We are proposing to adapt the ROBIN mechanisms of research to
enable a deep dive into the field of radiation (RT) and immunity. Representatives from seven international
academic centers already engaged in RT and immunity research have converged to participate in a small
prospective clinical trial (accrual: 25 patients in US and 25 patients in Europe), to synergize and accelerate
discovery. The setting of preoperative short course radiotherapy (SCRT) in rectal cancer, has emerged as ideal
for the scientific questions posed. SCRT is a standard treatment, preceded and followed by colonoscopies to
respectively assess tumor baseline extent and response (at the end of RT): during each colonoscopy consenting
patients can donate a tumor biopsy, as well as stool and blood (PBMC) samples. The same set of specimens
can be harvested, six weeks later at surgery, where research sampling of lymph nodes will also be possible,
within and outside the RT field. These sequential sets of tissues will enable us to conduct cutting edge multiple
“omics” approaches to study irradiated normal and cancer tissue and the microbiome in the RT field. The PBMC
analysis will allow correlation at a single cell level between RT-induced oxidative stress, changes in
immunophenotype and PBMC biology. Similarly, the ability to analyze lymph nodes harvested inside and outside
the radiation field will allow to pinpoint at the single cell level the RT effects on each immune subpopulation. The
longitudinal analysis on cancer biopsy, collected before and after RT and at surgery, will give a snapshot on the
RT-induced “omics” changes. An orthogonal radiomic study will analyze MR images obtained before SCRT and
before surgery (also standard imaging procedures in rectal cancer) together with images obtained at CT
simulation. Compliance with international regulations for data sharing, standardization of procedures and data
acquisition and harmonization of uploaded data will be essential to this effort. Advanced bioinformatics tools will
be applied through a dedicated Data Sharing and Integrative Analysis Core, capable to deconvolute and interpret
complex biological and imaging data, sorted by utilizing NCI FireCloud workspaces. By converging experienced
clinical investigators, bio-scientists and bio-informaticians to address fundamental radiation biology questions,
this ROBIN will rapidly enable unprecedented discovery that will be shared with the ROBIN network and the
scientific community at large.
Finally, since inception, ROBIN has revealed an optimal environment for cross-training and cross-fertilization of
the scientists and clinicians involved in the grant preparation and has created a robust foundation for the
proposed Cross Training Core, a novel structure to form future leaders in radiation oncology and biology, a task
each of the three P.I.s consider crucial to the future of our discipline.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph O Deasy其他文献
Joseph O Deasy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph O Deasy', 18)}}的其他基金
Dynamics of Immune Response in Irradiated Rectal Cancer
受照射直肠癌免疫反应的动态
- 批准号:
10708019 - 财政年份:2022
- 资助金额:
$ 171.12万 - 项目类别:
Dose-distribution radiomics to predict morbidity risk in radiotherapy
剂量分布放射组学预测放射治疗的发病风险
- 批准号:
9477682 - 财政年份:2016
- 资助金额:
$ 171.12万 - 项目类别:
Dose-distribution radiomics to predict morbidity risk in radiotherapy
剂量分布放射组学预测放射治疗的发病风险
- 批准号:
9271942 - 财政年份:2016
- 资助金额:
$ 171.12万 - 项目类别:
Normal Tissue Complication Modeling for Radiotherapy
放射治疗的正常组织并发症建模
- 批准号:
7913472 - 财政年份:2009
- 资助金额:
$ 171.12万 - 项目类别:
Normal Tissue Complication Modeling for Radiotherapy
放射治疗的正常组织并发症建模
- 批准号:
8204059 - 财政年份:2009
- 资助金额:
$ 171.12万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 171.12万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 171.12万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 171.12万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 171.12万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 171.12万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 171.12万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 171.12万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 171.12万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 171.12万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 171.12万 - 项目类别:














{{item.name}}会员




